Whatsapp
X
Mail
Copy link ICL Growing Solutions Announces Acquisition of Lavie Bio
We are excited to announce ICL Growing Solutions’ fourth acquisition in the past 13 months: Lavie Bio, a leader in microbiome-based agricultural solutions.
Through this acquisition, ICL will gain Lavie Bio’s core team, microbial bank, and key technology assets, further strengthening our biological portfolio and expanding our capabilities in sustainable farming technologies.
About Lavie Bio
Lavie Bio, based in Israel, is recognized for its cutting-edge biostimulants and biopesticides. This acquisition builds on more than two years of collaboration between ICL and Lavie Bio, particularly in developing innovative biostimulant solutions for row crops. By combining Lavie Bio’s advanced technology with ICL’s R&D expertise, we will enhance our position in the biologicals sector and bring more sustainable solutions to farmers worldwide.
Key Benefits of the Acquisition
- MicroBoost™ AI Technology: ICL will gain perpetual, royalty-free access to Evogene’s MicroBoost AI technology, accelerating our biological R&D and reducing time-to-market for new products.
- Talented Scientific Team: Lavie Bio’s experienced team will enhance our biological product development capabilities.
- Global Microbial Collection: With over 150,000 microbial strains, we can develop targeted, crop-specific solutions for different regions.
- Predictive Product Development: Lavie Bio’s technology enables us to design and predict the effectiveness, safety, and stability of biological products with greater precision.
- Integration with ICL’s Portfolio: Future Ag-biological products will be embedded with ICL’s fertilizers, leveraging our expertise in specialty fertilizer methodologies to develop next-generation solutions.
Leadership and Continuity
The Lavie Bio team will continue to lead their operations and drive research programs dedicated to ICL’s global needs. They will be fully integrated into the Growing Solutions Global R&D organization, reporting to Dr. Elinor Erez, VP R&D.
This acquisition reflects our commitment to expanding our biological portfolio, driving agricultural innovation, and supporting sustainable farming practices. Together, we are shaping a more sustainable future for agriculture.
